Global Atopic Dermatitis Medical Lead

Job title: Global Atopic Dermatitis Medical Lead

Location: Cambridge, MA / Morristown, NJ

About the job

Join the engine of Sanofi’s mission — where deep immunoscience meets bold, AI-powered research. In R&D, you’ll drive breakthroughs that could turn the impossible into possible for millions. 

Job Summary:

The Global Atopic Dermatitis Medical Lead is a pivotal role within Sanofi's Dupixent Medical Franchise, driving strategic initiatives and innovation in the dermatology therapeutic area. Reporting to the Global Medical Head of Dermatology, Alliance Immunology, this leader will spearhead the global medical strategy for Atopic Dermatitis (AD) in adults and pediatric population, working in close partnership with Regeneron to establish Dupixent as the definitive leader in dermatology.

This role demands excellence in strategic leadership, operational execution, and cross-functional collaboration. The successful candidate will shape the future of AD treatment through evidence generation, external engagement, and team leadership while upholding the highest ethical, regulatory, and scientific standards. This position offers a unique opportunity to make a significant impact on patient care worldwide.

About Sanofi 

We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. 

Main Responsibilities:

Medical Strategy & Execution (35%)

• Provide strategic input for the elaboration of the global brand plan by being the center of scientific expertise and develop an aligned medical affairs plan to support the brand strategy.

• Co-develop brand strategic imperatives for Dupixent in AD.

• Develop and implement a strong advocacy plan with experts in the field, academics, payers, providers and professionals and/or patient associations.

• Ensure a patient-centric approach to development of medical strategy both for product and device development as well as possible services which can enhance the value proposition of the product.

• Serve as the scientific expert for the cross-functional franchise, guiding medical strategy, evidence generation, and external engagement.

External Engagement & Launch Excellence (25%)

• Lead global and guide countries strategy in AD by establishing scientific leadership in the field by focusing on key pathways such as IL4/IL13, type 2 inflammation narrative, disease modification and pediatric population.

• Develop a robust advocacy program by organizing advisory boards and roundtables during major congresses, to build and reinforce product awareness, gather strategic insights, and foster relationships with key external stakeholders.

• Ensure the scientific and ethical integrity of sponsored and supported research, information, and relationships with healthcare providers and patient advocacy groups.

• Implement digital strategies such as virtual advisory boards, webinars, and interactive online platforms to reach a broader audience and facilitate efficient information exchange.

Evidence Generation & Publication (15%)

• Support development of a comprehensive post-marketing evidence portfolio including observational studies, registries, and real-world evidence (RWE) initiatives that demonstrate Dupixent's safety, efficacy, and value.

• Play a critical role in designing the Integrated Evidence Generation Plan (IEGP), ensuring strategic alignment with brand objectives and the Target Product Profile (TPP).

• Lead execution of post-approval studies with rigorous scientific standards, clear protocols, and quality oversight.

• Co-develop and implement strategic publication plans to disseminate key findings through peer-reviewed journals, conferences, and scientific forums.

• Foster collaborations with academic institutions and research organizations to enhance the scope and impact of evidence generation activities.

• Ensure data-driven decision-making by leveraging clinical insights, competitive intelligence, and RWE in collaboration with cross-functional teams.

Cross-functional Collaboration (15%)

• Collaborate cross-functi